Article Text

0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.